Morgan Stanley Cel Sci Corp Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Cel Sci Corp stock. As of the latest transaction made, Morgan Stanley holds 14,336 shares of CVM stock, worth $8,601. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,336

Previous 23,621 39.31%

Holding current value

$8,601

Previous $27,000 44.44%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.05 - $1.5 $9,749 - $13,927	-9,285 Reduced 39.31%	14,336 $15,000
Q2 2024 Oct 17, 2024	BUY	$1.11 - $1.85 $6,107 - $10,178	5,502 Added 30.37%	23,621 $27,000
Q2 2024 Aug 14, 2024	BUY	$1.11 - $1.85 $6,107 - $10,178	5,502 Added 30.37%	23,621 $27,000
Q1 2024 Oct 17, 2024	SELL	$1.63 - $3.08 $8,968 - $16,946	-5,502 Reduced 23.29%	18,119 $34,000
Q1 2024 Aug 16, 2024	SELL	$1.63 - $3.08 $41,204 - $77,859	-25,279 Reduced 58.25%	18,119 $34,000
Q1 2024 May 15, 2024	SELL	$1.63 - $3.08 $41,204 - $77,859	-25,279 Reduced 58.25%	18,119 $34,000
Q4 2023 Aug 16, 2024	BUY	$1.07 - $3.07 $21,161 - $60,715	19,777 Added 83.73%	43,398 $118,000
Q4 2023 Feb 13, 2024	BUY	$1.07 - $3.07 $25,790 - $73,996	24,103 Added 124.92%	43,398 $118,000
Q3 2023 Nov 15, 2023	SELL	$1.17 - $2.86 $2,940 - $7,187	-2,513 Reduced 11.52%	19,295 $24,000
Q2 2023 Aug 14, 2023	SELL	$2.11 - $2.83 $7,420 - $9,953	-3,517 Reduced 13.89%	21,808 $52,000
Q1 2023 May 15, 2023	SELL	$2.17 - $3.13 $14,499 - $20,914	-6,682 Reduced 20.88%	25,325 $58,000
Q4 2022 Feb 14, 2023	SELL	$1.99 - $3.52 $15,076 - $26,667	-7,576 Reduced 19.14%	32,007 $75,000
Q3 2022 Nov 14, 2022	SELL	$3.09 - $5.23 $339,214 - $574,138	-109,778 Reduced 73.5%	39,583 $122,000
Q2 2022 Oct 27, 2022	BUY	$2.58 - $4.99 $131,360 - $254,065	50,915 Added 51.72%	149,361 $671,000
Q2 2022 Aug 15, 2022	BUY	$2.58 - $4.99 $131,360 - $254,065	50,915 Added 51.72%	149,361 $671,000
Q1 2022 Oct 27, 2022	SELL	$3.93 - $7.7 $200,095 - $392,045	-50,915 Reduced 34.09%	98,446 $386,000
Q1 2022 May 13, 2022	BUY	$3.93 - $7.7 $65,784 - $128,890	16,739 Added 20.49%	98,446 $386,000
Q4 2021 Feb 14, 2022	BUY	$7.1 - $12.82 $65,007 - $117,379	9,156 Added 12.62%	81,707 $581,000
Q3 2021 Nov 15, 2021	BUY	$7.64 - $12.49 $554,289 - $906,161	72,551 New	72,551 $797,000

Others Institutions Holding CVM

# of Institutions

Shares Held

Call Options Held

27.1K

Put Options Held

150K

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account